Published in Medical Letter on the CDC and FDA, September 28th, 2003
According to a study from the United Arab Emirates, Jordan, and Brazil, "The pharmacokinetics of two brands of simvastatin 40-mg tablets were compared in 24 healthy human volunteers after a single oral dose in a randomized cross-over study, conducted at IPRC, Amman, Jordan," reported Naji M. Najib at the International Pharmaceutical Research Centre (IPRC) in Amman, Jordan and collaborators in Jordan, the United Arab Emirates, and Brazil.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.